Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
< Previous
1
2
Next >
Europe's pharma industry braces for tariffs as carve-out hopes fade
April 02, 2025
Tags
Health & Science
Bavarian Nordic A/S
Health care industry
From
CNBC.com News
Hims & Hers shares rise as company adds new weight-loss medications to platform
April 01, 2025
Tags
Breaking News: Technology
Health care industry
Technology
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Health & Science
GSK plc
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
April 01, 2025
Tags
Biotech and Pharmaceuticals
Healthy Returns
Merck & Co Inc
From
CNBC.com News
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
April 01, 2025
Tags
Social issues
Health & Science
Business
From
CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
March 29, 2025
Tags
Health care industry
Pharmaceuticals
Companies
From
CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
March 28, 2025
Tags
Pharmaceuticals
Biotechnology
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
March 27, 2025
Tags
Novo Nordisk A/S
Pharmaceuticals
Biotechnology
From
CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
March 25, 2025
Tags
LILLY DRN
Science
Novo Nordisk A/S
From
CNBC.com News
5 things to know before the stock market opens Tuesday
March 25, 2025
Tags
Business News
LILLY DRN
Investing
From
CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
March 24, 2025
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Roche Holding AG
From
CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
March 24, 2025
Tags
Biotech and Pharmaceuticals
LILLY DRN
Biotechnology
From
CNBC.com News
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
March 24, 2025
Tags
Apple Inc
AstraZeneca PLC
Airbus SE
From
CNBC.com News
Zepbound copycats remain online despite FDA ban
March 21, 2025
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Science
From
CNBC.com News
Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate
March 12, 2025
Tags
Roche Holding AG
Biotech and Pharmaceuticals
LILLY DRN
From
CNBC.com News
White House: Stock market plunge is not as 'meaningful' as business activity
March 10, 2025
Tickers
CEOS
Tags
Political Leaders
Business News
LILLY DRN
From
CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
March 05, 2025
Tags
Business
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
March 05, 2025
Tags
Companies
Pharmaceuticals
Health care industry
From
CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
March 04, 2025
Tags
Health care industry
Structure Therapeutics Inc
LILLY DRN
From
CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
February 26, 2025
Tags
Health care industry
Pharmaceuticals
Companies
From
CNBC.com News
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
February 25, 2025
Tags
Business
Health & Science
Companies
From
CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
February 21, 2025
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health & Science
From
CNBC.com News
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
February 20, 2025
Tags
Health care industry
LILLY DRN
Science
From
CNBC.com News
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
February 20, 2025
Tags
Biotech and Pharmaceuticals
Health & Science
Science
From
CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
Tags
Healthy Returns
Biotech and Pharmaceuticals
CVS Health Corp
From
CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
February 13, 2025
Tags
Ford Motor Co
Mercedes/Benz Group AG
Amazon/com Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 06, 2025
Tags
Amazon/com Inc
NVIDIA Corp
LILLY DRN
From
CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
Tags
Health & Science
Business
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
February 06, 2025
Tags
Health care industry
Pharmaceuticals
Companies
From
CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
Tags
Biotech and Pharmaceuticals
Health & Science
Novo Nordisk A/S
From
CNBC.com News
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.